Raymond James Financial
BBP icon

Raymond James Financial’s Virtus Biotech ETF BBP Stock Holding History

Raymond James Financial’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
17,304
+11,061
+177% +$909K ﹤0.01% 3597
2025
Q4 		$499K Sell
6,243
-275
-4% -$20.9K ﹤0.01% 4267
2025
Q3 		$456K Sell
6,518
-10,915
-63% -$715K ﹤0.01% 4169
2025
Q2 		$1.02M Sell
17,433
-7,359
-30% -$416K ﹤0.01% 3580
2025
Q1 		$1.45M Buy
24,792
+16,866
+213% +$1.03M ﹤0.01% 3215
2024
Q4 		$476K Buy
+7,926
New +$501K ﹤0.01% 3942

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Raymond James Financial's BBP Position: Q1 2026 in Review

Raymond James Financial increased its Virtus Biotech ETF (BBP) stake by 177% in Q1 2026, buying an estimated $909K and bringing the position to 17,304 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Raymond James Financial first reported a position in BBP in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.45M in Q1 2025. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Raymond James Financial held 17,304 shares of Virtus Biotech ETF worth $1.44M as of Q1 2026.
  • Raymond James Financial bought 11,061 Virtus Biotech ETF shares in Q1 2026, an estimated $909K.
  • Virtus Biotech ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3597 holding.
  • Raymond James Financial first reported a position in Virtus Biotech ETF in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Virtus Biotech ETF position peaked at $1.45M in Q1 2025.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.